Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CASPOFUNGIN Cause Product prescribing issue? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Product prescribing issue have been filed in association with CASPOFUNGIN (CASPOFUNGIN ACETATE). This represents 0.2% of all adverse event reports for CASPOFUNGIN.

9
Reports of Product prescribing issue with CASPOFUNGIN
0.2%
of all CASPOFUNGIN reports
1
Deaths
5
Hospitalizations

How Dangerous Is Product prescribing issue From CASPOFUNGIN?

Of the 9 reports, 1 (11.1%) resulted in death, 5 (55.6%) required hospitalization.

Is Product prescribing issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CASPOFUNGIN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does CASPOFUNGIN Cause?

Drug ineffective (1,060) Off label use (325) Product use in unapproved indication (257) Multiple organ dysfunction syndrome (215) Drug resistance (194) Septic shock (165) Aspergillus infection (154) Drug reaction with eosinophilia and systemic symptoms (136) Systemic mycosis (129) Pyrexia (128)

What Other Drugs Cause Product prescribing issue?

DUPILUMAB (1,715) POLYETHYLENE GLYCOL 3350 (1,439) LENALIDOMIDE (948) OXYCODONE (646) RIVAROXABAN (359) ACETAMINOPHEN\OXYCODONE (347) ETONOGESTREL (311) ACETAMINOPHEN\HYDROCODONE (298) CERTOLIZUMAB PEGOL (297) CABOZANTINIB S-MALATE (294)

Which CASPOFUNGIN Alternatives Have Lower Product prescribing issue Risk?

CASPOFUNGIN vs CATEQUENTINIB CASPOFUNGIN vs CC-4047 CASPOFUNGIN vs CEDAZURIDINE\DECITABINE CASPOFUNGIN vs CEDIRANIB CASPOFUNGIN vs CEFACLOR

Related Pages

CASPOFUNGIN Full Profile All Product prescribing issue Reports All Drugs Causing Product prescribing issue CASPOFUNGIN Demographics